60
Participants
Start Date
December 1, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Intralipid
Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.
Palm Oil Emulsion
Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.
Saline
All participants will serve as their own controls with a saline infusion study day.
RECRUITING
Mayo Clinic, Rochester
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Mayo Clinic
OTHER